• Date of Publication: 10 May 2021
  • Status:  Assessment Complete
  • Type of Health Technology: Drugs
  • HTA Track: Expedited Track
  • Topic Assignment: Internal Assessment Group
  • Recommendation Status:  Cannot Recommend
    There is insufficient evidence at this point to recommend the use of favipiravir to patients diagnosed with COVID-19.
  • Secretary of Health Decision Status: Available
  • Evidence and Relevant Links:

History